SuperworthNuvectis Pharma shares outstanding NVCT
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 23.5M
- On a year earlier
- +9.9%
- more shares
Nuvectis Pharma had 23.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 9.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 23.2M | +31% |
| FY2024 | 17.8M | +10% |
| FY2023 | 16.2M | +11% |
| FY2022 | 14.6M | +225% |
| FY2021 | 4.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 23.5M | +10% | |
| Q1 FY26 | 23.4M | +17% | |
| Q4 FY25 | 23.2M | +31% | |
| Q3 FY25 | 22.7M | +32% | |
| Q2 FY25 | 21.4M | +26% | |
| Q1 FY25 | 19.9M | +20% | |
| Q4 FY24 | 17.8M | +10% | |
| Q3 FY24 | 17.2M | +7% | |
| Q2 FY24 | 16.9M | +11% | |
| Q1 FY24 | 16.6M | +12% | |
| Q4 FY23 | 16.2M | +11% | |
| Q3 FY23 | 16.1M | +15% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Nuvectis Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.